Caterina Casari, PhD

Principal Investigator
UMR_S 1176

Caterina Casari, PhD, researcher at Inserm U1176 - HITh lab- at Le Kremlin Bicetre, France.
My research studies are mainly focused on von Willebrand factor and his partners. I am interested in developing in vitro & in vivo models to elucidate molecular mechanisms underlying unsolved clinical aspects of congenital and acquired von Willebrand disease. I am also interested in exploring new molecular strategies that can be applied as therapeutic approaches for VWF-associated disorders.

Presentation(s):

• TRA 01.1 - Introduction

  Saturday, July 9, 2022
  8:30 AM – 8:35 AM

• OC 22.4 - Unique humanized mouse models of von Willebrand disease to implement the need for innovative therapeutic strategies

  Sunday, July 10, 2022
  3:30 PM – 3:45 PM

• OC 43.5 - Domain-specific nanobodies distinguish intact and proteolyzed forms of von Willebrand factor in congenital von Willebrand disease

  Monday, July 11, 2022
  3:45 PM – 4:00 PM

• PB0817 - Emicizumab ameliorates hemostasis in von Willebrand Disease type 3 but not type 2A murine models

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• SOA 15.4 - The Future of Gene Therapy

  Tuesday, July 12, 2022
  8:00 AM – 9:15 AM

• OC 50.4 - Differences in bleeding profiles and venous clot structures between emicizumab and factor VIII-treated mice

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM